Detalhe da pesquisa
1.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol
; 204(3): 877-886, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952982
2.
Quantification of azacitidine incorporation into human DNA/RNA by accelerator mass spectrometry as direct measure of target engagement.
J Pharm Biomed Anal
; 202: 114152, 2021 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051483
3.
Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy.
Leukemia
; 37(1): 240-243, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437356